Search Results - "Oktora, Monika P"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Trends in polypharmacy and dispensed drugs among adults in the Netherlands as compared to the United States by Oktora, Monika P, Denig, Petra, Bos, Jens H J, Schuiling-Veninga, Catharina C M, Hak, Eelko

    Published in PloS one (22-03-2019)
    “…Polypharmacy is becoming increasingly common owing to the ageing population, which can pose problems for patients and society. We investigated the trends in…”
    Get full text
    Journal Article
  2. 2

    Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies by Daud, Aizati N A, Bergman, Jorieke E H, Oktora, Monika P, Kerstjens-Frederikse, Wilhelmina S, Groen, Henk, Bos, Jens H, Hak, Eelko, Wilffert, Bob

    Published in PloS one (13-03-2017)
    “…A number of transporter proteins are expressed in the placenta, and they facilitate the placental transfer of drugs. The inhibition of P-glycoprotein (P-gp)…”
    Get full text
    Journal Article
  3. 3

    Sex disparities in treatment patterns after metformin initiation among patients with type 2 diabetes mellitus by Oktora, Monika P, de Vos, Stijn, de Vries, Sieta T, Hak, Eelko, Denig, Petra

    Published in Pharmacoepidemiology and drug safety (01-12-2023)
    “…To assess sex differences in treatment patterns after metformin initiation among type 2 diabetes mellitus (T2D) patients. A cohort study was conducted using…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Increased life expectancy as a result of non-hormonal targeted therapies for HER2 or hormone receptor positive metastatic breast cancer: a systematic review and meta-analysis by Koleva-Kolarova, Rositsa G, Oktora, Monika P, Robijn, Annelies L, Greuter, Marcel JW, Reyners, Anna KL, Buskens, Erik, Bock, Geertruida H de

    Published in Cancer treatment reviews (01-04-2017)
    “…Highlights • Non-hormonal targeted therapies demonstrated better efficacy as compared to other treatments. • Non-hormonal targeted therapies could potentially…”
    Get full text
    Journal Article